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Introduction 
With funding from the Centers for Disease Control and Prevention (CDC) and the National 
Association of County and City Health Officials (NACCHO), the NORC Walsh Center for Rural 
Health Analysis and the University of Kentucky Center of Excellence in Rural Health (UK 
CERH) conducted this study to understand possible factors associated with declining rates of 
drug overdose mortality in Eastern Kentucky. Several counties in Eastern Kentucky have seen 
declines in drug overdose mortality rates over the past decade, even as overdose rates have risen 
in the state of Kentucky as a whole, as well as in the Appalachian regions of neighboring states 
such as Pennsylvania, Ohio, and West Virginia. Through an intensive qualitative study, NORC 
and UK CERH identified potential policies and strategies that may be contributing to the 
declines, including approaches that could be implemented in other communities. 
Background 
In October 2018, NORC released an opioid mapping tool (http://opioidmisusetool.norc.org), 
which provided county-level drug overdose mortality data for two 5-year time periods.1 Drug 
overdose mortality data was obtained from the CDC National Center for Health Statistics 
(NCHS) National Vital Statistics System (NVSS).2 Drug overdose mortality was determined 
using the standard International Classification of Diseases 10th Revision (ICD-10) underlying 
cause-of death codes used by CDC (X40-X44, X60–X64, X85, and Y10–Y14). The tool 
highlighted the declining drug overdose mortality rates in Eastern Kentucky, in contrast to other 
neighboring states. Based on data through 2017, we determined that between 2008-2012 and 
2013-2017, of the 10 counties nationally with the largest decline in drug overdose mortality rate, 
8 were in Eastern Kentucky. Of the top 20 counties nationally, 14 were in Eastern Kentucky. 
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Table 1. Declines in Drug Overdose Mortality in Eastern Kentucky  
County Drug Overdose Mortality Rate  (2013-2017)^ 
Decline in Drug Overdose Mortality Rate 
between 2013-2017 and 2008-2012 
Clay 29.5 -52.2 deaths per 100,000 
Johnson 38.8 -49.7 deaths per 100,000 
Floyd 73.8 -34.0 deaths per 100,000 
Magoffin 35.6* -32.8 deaths per 100,000 
Breathitt 46.4 -32.0 deaths per 100,000 
Bath 44.2* -30.7 deaths per 100,000 
Powell 70.1 -30.4 deaths per 100,000 
Letcher 46.3 -28.8 deaths per 100,000 
^Age-adjusted drug overdose mortality rate per 100,000 for population ages 15-64. 
*Crude death rate provided for these counties, as fewer than 20 deaths were reported during the time period.  
Data Source: Mortality rates provided by Centers for Disease Control and Prevention, National Center for Health Statistics. Accessed at 
http://wonder.cdc.gov/mcd-icd10.html. ICD-10 codes: X40-X44, X60-X64, X85, Y10-Y14.   
 
Figure 1 shows county-level data comparing drug overdose mortality rate increases and 
decreases from 2008-2012 to 2013-2017. This graphic shows the cluster of counties in Eastern 
Kentucky where the rates declined between these two time periods, compared to the dramatic 
increases in Southwest Ohio, Southern West Virginia, and Southwest Pennsylvania.  
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Figure 1. Changes in Drug Overdose Mortality from 2008-2012 to 2013-2017    
 
Data Source: Mortality rates provided by Centers for Disease Control and Prevention, National Center for Health Statistics. Accessed at 
http://wonder.cdc.gov/mcd-icd10.html. ICD-10 codes: X40-X44, X60-X64, X85, Y10-Y14.   
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Figure 2 shows the trend in drug overdose mortality within the Appalachian counties of 
Kentucky, Ohio, and West Virginia, further highlighting the differences seen across Appalachian 
states. From 2011 to 2013, the drug overdose mortality rate decreased in Appalachian Kentucky, 
while rates remained fairly constant in Appalachian Ohio and West Virginia. Appalachian 
Kentucky did not experience the dramatic increase in drug overdose mortality between 2014 and 
2017 that occurred in Appalachian Ohio and West Virginia. Additionally, in 2019, drug overdose 
mortality rates increased in both Appalachian Ohio and West Virginia, following a decline in 
2018; however, Appalachian Kentucky did not experience the same increase.   
Figure 2. Drug Overdose Mortality (ages 15 to 64)*, among Appalachian Counties    
 
*Age-adjusted drug overdose mortality rate per 100,000 for population ages 15-64. 
Data Source: Mortality rates provided by Centers for Disease Control and Prevention, National Center for Health Statistics. Accessed at 
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Methodology  
We used a qualitative study design to explore research questions about the observed declines in 
overdose mortality rates in Eastern Kentucky. To guide the study’s research protocol, we 
conducted preliminary literature and media searches to understand the history of the region as it 
related to overdose mortality, and examined quantitative overdose mortality data through 
NORC’s overdose mapping tool.  
We also conducted an exploratory site visit to the region in November 2019. During this visit, 
our research team met with local stakeholders throughout Eastern Kentucky from several sectors, 
including representatives from the public health, criminal justice, economic development, health 
care, treatment, recovery, education, and advocacy sectors. UK CERH leveraged their 
connections within the region to recommend key stakeholders with in-depth experience and 
perspective that would be important to meet with during this visit. Additionally, we coordinated 
with a representative from the Kentucky Department for Public Health (KDPH), who helped 
arrange meetings with critical KDPH staff. During these informal meetings, we asked 
stakeholders two main hypothesis-generating questions to inform the study design and protocol 
and to elicit meaningful and relevant information during final data collection:  
1) Based on your experience and expertise, what hypotheses do you have for why drug overdose 
rates in Eastern Kentucky may be declining?  
2) When we conduct formal data collection, who are the key stakeholders we should interview?   
Data Collection  
Although we intended to collect data during a second site visit, due to COVID-19 travel 
restrictions we shifted to remote data collection, conducting 38 semi-structured telephone 
interviews with key stakeholders in the Eastern Kentucky region. The NORC Institutional 
Review Board (IRB) reviewed the study and determined the data collection was not human 
subjects research. Before each interview, the NORC interviewer conducted informed consent 
with the participant.  
We formally interviewed several of the stakeholders that participated in the exploratory site visit 
in 2019, along with additional stakeholders identified by NORC and UK CERH. UK CERH 
supported NORC with recruitment for interviews among the substance use stakeholders from the 
region. The semi-structured nature of the interviews allowed us to explore various topics related 
to the factors the stakeholders believed to be contributing to declining overdose mortality rates. 
Stakeholder groups included representatives from the following sectors: criminal justice (9 
interviews); prevention/education (7); economic development and recovery (6); treatment (6); 
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state and local health departments (5); health care (3); and harm reduction (2). We intended to 
conduct a focus group with individuals actively in treatment, but due to COVID-19 travel 
restrictions and social distancing guidelines we were unable to travel to the region.  
We used the same interview protocols with all stakeholder groups to ensure that we captured a 
diverse set of perspectives across research questions. The interviews explored the respondents’ 
initial reaction to observed declines in overdose mortality and perceptions as to what may have 
driven these declines. Protocol topics explored key hypotheses related to increased access to 
treatment and recovery; Medicaid expansion; law enforcement and the criminal justice system; 
harm reduction; primary prevention and community coalitions; and shifts in drugs of choice. The 
research protocols also encouraged respondents to discuss other potential factors contributing to 
declines in overdose mortality; data sources; study implications; and strategies for dissemination 
of findings.  
Data Analysis  
The project team conducted a thematic analysis of qualitative data using NVivo qualitative 
analysis software (QSR International Pty Ltd., Melbourne, Australia). We developed a codebook 
to identify themes and topics of interest based on the research hypotheses developed after the 
initial site visit. Coded themes included reactions to overdose data, shift in drug availability or 
use, increased access to treatment, criminal justice system, recovery community, harm reduction, 
prevention/education, stigma, and partnerships/longstanding commitment. The study team 
participated in an iterative process to develop and refine the codebook. We used the codebook to 
analyze the data and inductively identified additional findings. The analysis culminated in this 
written report. 
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Findings 
I. Stakeholder Reactions to Trends in Drug Overdose Mortality  
At the beginning of each interview, we briefly explained the observed trends in overdose 
mortality in Eastern Kentucky. We noted that 8 of the 10 counties nationally that have seen the 
largest decline in overdose mortality rates from the two time periods 2008-2012 and 2013-2017 
were in Eastern Kentucky—and then asked if the respondent was surprised by these data. 
Respondent reactions varied. Some interviewees were surprised, especially at the depth of 
improvement in Eastern Kentucky. One surprised respondent who worked in substance use 
treatment noted that they have not seen changes in terms of the number of individuals seeking 
treatment at their facility. Others were not surprised by the findings, and one interviewee shared, 
“We know we have one of the highest addiction rates, but I think we are taking huge leaps 
towards correcting the problem and getting people the help. It doesn’t surprise me.” Some who 
were not surprised described the reasons why they believed Eastern Kentucky has seen declines 
in drug overdose mortality, which is explained in more detail in the next section.  
II. Policies, Programs, and Interventions Potentially Contributing to Decline in 
Drug Overdose Mortality  
A. Improving Prescribing Behaviors  
Kentucky has implemented several policies over the past decade designed to limit the availability 
of prescription opioids, which was driving overdose mortality rates in Eastern Kentucky in the 
late 2000s and early 2010s.3 Many interview respondents indicated that less access to 
prescription opioids is likely contributing to the declines in drug overdose mortality. As stated by 
one respondent, “I think initially in the early stages, if you saw declining rates, it may have been 
success in the prescription drug diversion problem.” Respondents described the legislation that 
has made it more difficult for doctors to prescribe opioids in large quantities. Kentucky was one 
of the first states to launch a prescription drug monitoring program. In 1998, the Kentucky All 
Schedule Prescription Electronic Reporting (KASPER) system was created; however, it was not 
until 2012 when House Bill 1 passed that providers were required to use KASPER when 
prescribing controlled substances.4 Many interview respondents referenced this legislation as a 
major impact on the availability of opioids in Kentucky. In addition to requiring use of 
KASPER, House Bill 1 stated that “only a physician having a full and active license to practice 
medicine issued under KRS Chapter 311 shall have an ownership or investment interest in a pain 
management facility.”5 A representative from the Kentucky Office of Drug Control Policy 
reported that “from 2011 to 2018, 100 million fewer dosage units of opioids a year were 
prescribed…We got rid of 36 pain clinics. Low-hanging fruit with that 2012 legislation.”  
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B. Increasing Access to Substance Use Treatment  
One of the most commonly reported reasons for the decline of drug overdose mortality rates in 
Eastern Kentucky was increased access to substance use treatment providers over the past five 
years.6 Many interview respondents described the dramatic shift in the availability of treatment 
providers between the two time periods. As one respondent from the criminal justice sector 
stated, “I think that the access and availability of treatment resources in Eastern Kentucky has 
grown exponentially.”  
 
Respondents said that one of the major contributors to the increased access was implementation 
of the Affordable Care Act and Medicaid expansion. Kentucky expanded Medicaid in 2014, the 
same year as its Appalachian neighbors, Ohio and West Virginia, and one year before 
Pennsylvania.7 Both Kentucky and West Virginia saw notable declines in its uninsured 
population as a result. Between 2013 and 2016, the percentage of adults who lacked health 
insurance declined by 14.5 percentage points in Kentucky and by 19.3 percentage points in West 
Virginia. By comparison, the decline during the same time period was 7.5 percentage points in 
Pennsylvania and 7.4 percentage points in Ohio. Among neighboring states that did not expand 
Medicaid, the decline in the uninsured population between 2013 and 2016 was 9.4 percentage 
points in North Carolina, 2.9 percentage points in Tennessee and 2.3 percentage points in 
Virginia.8 In 2014 and 2016, Eastern Kentucky exhibited the largest portion of Medicaid 
enrollment across the state.9  
 
Prior to implementing the Affordable Care Act, Kentucky did not cover substance use disorder 
(SUD) treatment for Medicaid enrollees. Kentucky’s changes to its Medicaid program included 
the addition of a SUD treatment benefit for enrollees in Kentucky’s traditional Medicaid 
program9, as well as coverage for all levels of treatment, including residential treatment; 
intensive outpatient programs; medication-assisted treatment (MAT); and peer support.10 
Previously, treatment providers had to individually seek approval from the Centers for Medicare 
& Medicaid Services (CMS) to cover those services. The number of enrollees in Kentucky’s 
Medicaid expansion program receiving substance use services increased by more than 700 
percent between the first quarter of 2014 and the second quarter of 2016, from approximately 
1,500 to more than 11,000 care encounters.6 
 
Treatment providers discussed how Medicaid expansion and changes to traditional Medicaid 
have impacted their ability to provide substance use treatment services. By early 2015, one of the 
largest treatment providers in Eastern Kentucky, Addiction Recovery Care (ARC), admitted their 
first residential program patient under the new benefit structure. Since that time they have grown 
dramatically, admitting over 8,000 clients into residential treatment. They currently have 700 
employees, half of whom are in recovery and a third who are graduates of their program. Other 
treatment providers have experienced similar growth over this time frame. Nearly all of the 
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respondents attributed the increase in treatment availability in Eastern Kentucky to the expansion 
of Medicaid and other changes to the Medicaid program. As one respondent from the criminal 
justice sector said, “Medicaid expansion has made a tremendous difference. More folks are able 
to access treatment and more treatment exists because of the expansion. Before, for a treatment 
center to exist, they had no means of any kind of revenue. Now, they are able to leverage 
Medicaid, more treatment centers are able to exist and expand, and so many more people are able 
to access it.” Several respondents noted that prior to Medicaid expansion, Operation UNITE 
vouchers were critical in helping individuals seek addiction treatment. Founded in 2003, 
Operation UNITE is a nonprofit organization dedicated to preventing addiction and providing 
individuals with adequate access to addiction treatment resources. A representative from the 
criminal justice field stated that the Operation UNITE vouchers “were 10,000 times more 
important then, because now everyone is Medicaid covered.”  
Respondents also described the increased availability of a variety of treatment options, including 
MAT, as a factor in reduced overdose rates. One respondent described their personal experiences 
with SUD and the difficulty they had faced finding treatment options in Eastern Kentucky 10 
years ago: “I remember after one overdose, I ended up in a psychiatric ward, which was the 
closest thing to me that was open, the only place they had to put me. Now there are more detox 
and acute care centers, more access to MAT.” Kentucky continues to expand access to MAT 
through its state Medicaid program; for example, in 2019, in addition to buprenorphine and 
Vivitrol, Kentucky Medicaid began covering methadone as another method of MAT.11 Some of 
the success stories associated with increased treatment access in Eastern Kentucky included 
shorter waiting times and the greater availability of evidence-based treatment models. One 
respondent noted that they can now “get people treatment on demand,” which has led to the 
region “starting to turn the corner on addiction.” Other treatment components that respondents 
highlighted included the longer terms of many programs, in addition to the focus on skill 
development and employment. As one respondent said, “Some of the largest and most successful 
treatment providers have plans to keep their clients from 90 days up to as much as a year.” The 
respondent reported that in these programs, treatment providers were able to bill Medicaid for 
the residential stay, then for intensive outpatient case management and peer support. After that 
point, they often hired clients to work as peer recovery specialists or for social enterprises such 
as bakeries, automotive shops, and small construction companies.  
Respondents also described the wide range of ways that people could access treatment in Eastern 
Kentucky, from referrals from judges, law enforcement, or harm reduction sites, to finding 
services through community organizations, such as Operation UNITE. Respondents noted that 
the treatment landscape has evolved dramatically in Eastern Kentucky over the past 5 to 10 
years, which they believe had a notable impact on the declining rates of drug overdose mortality.  
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C. Focus on Individuals in Recovery  
Respondents described a significant focus on supporting individuals in recovery across Eastern 
Kentucky, specifically in terms of second chance employment, recovery housing, and peer 
support. Stakeholders in Eastern Kentucky reported that they recognized the benefit of 
incorporating employment opportunities into the recovery journey. For example, a stakeholder 
from the criminal justice field shared that the local “chamber of commerce is connected to these 
issues, pulling in employers around the state and talking about hiring folks with SUD and who 
have been formerly incarcerated.” Additionally, one respondent said, “Now employers are 
working with treatment centers to help provide clients with meaningful employment which is so 
essential in recovery because purpose is so essential in recovery. The willingness of employers to 
hire people with a record or a history of addiction has helped keep people in recovery, which 
ultimately would contribute to the decline in mortality rates.” Respondents described that 
organizations working on SUD issues in Eastern Kentucky realized the need for a holistic 
approach to treatment. A representative from the economic development sector highlighted this 
point when discussing Eastern Kentucky communities, stating that “a lot of times the capacity to 
find meaningful solutions resides in communities.”   
Several respondents also discussed the Recovery Kentucky model as a factor contributing to 
declining drug overdose mortality rates. The Recovery Kentucky model was originally 
developed under Governor Fletcher in 2007, and was a joint effort between the Kentucky 
Department for Local Government, the Department of Corrections, and Kentucky Housing 
Corporation. Currently, 14 Recovery Kentucky centers across the commonwealth provide 
housing and recovery services for up to 2,000 Kentuckians across the state.12  
Another respondent described seeing growth in the number of Alcoholics Anonymous and 
Narcotics Anonymous meetings, and that recovery was celebrated in a way it was not previously. 
Additionally, respondents shared that as the recovery community grew, individuals in the early 
stages of recovery had many role models that demonstrated recovery success, which gave them 
hope as they go through their own recovery journey.  
D. Evolving Approach of the Criminal Justice System  
The criminal justice system, including police officers in law enforcement and local judges in the 
court system, interact at different stages of the criminal justice process with individuals who use 
drugs. In speaking with law enforcement stakeholders, we learned that there has been a shift in 
the role of police officers, from immediately arresting a person who uses drugs and initiating 
them into the court system, to trying to refer these individuals to treatment. The Kentucky State 
Police started the Angel Initiative in 2016, allowing anyone experiencing SUD to come into a 
post and receive help in finding and accessing treatment.13  This has been a valuable and 
impactful program, according to interviewees. Operation UNITE worked closely with the Angel 
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Initiative, providing treatment vouchers that helped individuals quickly connect with treatment 
options. One interviewee said, “We [police officers] still do enforcement, but we also have 
another avenue. The idea is that we get involved before they get to the criminal justice system 
because of decisions they’re making because of addiction. Get them earlier on before they rack 
up charges and felonies.” One interviewee from the health care sector noted that in some 
communities, while attitudes among law enforcement have been “changing…for the better as far 
as understanding SUD,” they were still not consistent across the region and depended on police 
leadership.  
The other key aspect of the criminal justice system that has influenced declining overdose 
mortality rates, according to respondents, was the changing approach within the judicial system 
and the impact of local judges. One participant from the Kentucky state government candidly 
shared, “Our first step, which was to incarcerate our way out of the problem, has proven to be a 
disaster.” Interviewees described how judges across Eastern Kentucky have shifted from 
sentencing people who use drugs to prison, to looking for alternative sentencing options and 
opportunities to provide support. Judges were able to send individuals directly to treatment. 
Several respondents specifically mentioned the work of a district court judge with whom we 
spoke. He noted that he had sent 256 residents from his county to treatment in 2019 and 
described the dedication and commitment within his county to help individuals suffering from 
SUD find treatment. He stated, “Out of the 256, I’m guessing the county jailor or sheriff drove 
100 of those people to treatment.” Within his court he integrated a peer support specialist from a 
local treatment facility who served as a community liaison five days a week. The peer support 
specialist experienced similar struggles as the individuals coming through the court system, so 
they trusted him; he provided a warm hand off to the treatment facilities.  
While the judge that we interviewed operates outside of a formal drug court, other respondents 
specifically discussed the potential positive impact of drug courts. Drug courts are specialty 
courts where individuals complete a substance use treatment program under the supervision of a 
judge,14 or another alternative to incarceration. Representatives from Operation UNITE noted 
that when the organization was founded, there were only five drug courts in the 5th 
Congressional District, which includes most of Eastern Kentucky. Now, every county in the 
district operates a drug court, as do 113 of 120 counties in Kentucky.15 Operation UNITE 
worked with the Administrative Office of the Courts to expand these specialty courts. Overall, 
respondents discussed the benefits of drug courts; however, some noted that the effectiveness of 
the drug courts could vary by county.  
E. Expansion of Syringe Services Programs 
Many interviewees commented on the benefits of syringe services programs (SSPs) in Eastern 
Kentucky. Kentucky SB 192, passed in 2015, allowed local health departments to operate Harm 
NORC | Understanding Declining Rates of Drug Overdose in Eastern Kentucky 
FINAL REPORT | 12 
Reduction and Syringe Exchange Programs (HRSEP).16 To start a HRSEP in a local community, 
the local health department, the city government legislative body, and the county government 
legislative body all had to agree on the decision. One interviewee from the Kentucky state 
government said, “I think…the communities deserve credit because they rose up. The way the 
law was passed was each community had to initiate the decision to open one. They have to get 
approval, and it took a lot of ground work from those communities, but they became tired of 
losing their loved ones…I think that is significant that we had a local grassroots effort to do harm 
reduction and get folks Narcan.” As of October 19, 2020, Kentucky has 74 harm reduction sites, 
most of which are situated in the eastern region of the state.17 This number was greater than all 
neighboring states, including Ohio, West Virginia, and Tennessee. Ohio had 32 harm reduction 
sites, 8 of which were located in Appalachian counties18; West Virginia had 18 sites19; and 
Tennessee had 7 sites, 3 of which were located in Appalachian counties.20 
 
Interviewees commented on how SSPs are a safe space for individuals who use drugs to learn 
about the effects of drug use and the resources available to them. One individual from a legal 
nonprofit noted, “Needle exchanges get people to resources in a beautiful open welcoming space. 
Even if you decide not to use those resources, you learn how to use drugs in a safer way.” 
Finally, interviewees noted that the expansion of SSPs in Eastern Kentucky provided another 
touchpoint for accessing treatment services.  
F. Increased Distribution of Naloxone 
Respondents mentioned another factor that may have reduced rates of drug overdose mortality: 
increased access to naloxone (Narcan). In addition to being distributed at SSPs, interviewees said 
that more police officers were being trained to use and carry naloxone in Eastern Kentucky. 
Local pharmacists also carried naloxone and were able to sell it and teach the community how to 
use it effectively.  
 
Interviewees shared that family members of individuals who used drugs were able to have 
naloxone close by in the event they needed to use it on their loved one. While naloxone may 
have played a role in reducing drug overdose deaths, many respondents shared that the notable 
increase in naloxone distribution has occurred over the past several years, and therefore may not 
have played as significant a role in mortality reductions observed in the time period of this study.   
G. Prevention and Education  
Stakeholders discussed prevention efforts and substance use education as contributing factors to 
the observed declines. There are a variety of prevention education programs, but the Eastern 
Kentucky region has a unique program—Operation UNITE. The UNITE approach engages 
adolescents and teens throughout their schooling via presentations and UNITE club, and in the 
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summers through Operation UNITE camp. An Operation UNITE representative shared that the 
organization employs 54 AmeriCorps educators who tutor children in academic subjects, for 
example math, because “there [are] data out there that show that students who are able to make 
advances academically have the lowest addiction rate.” By taking this interdisciplinary and 
holistic approach to helping children and adolescents, Operation UNITE strives to prevent 
substance use and addiction before it starts.21 A representative from the criminal justice sector 
noted that “if you are going to do a prevention education program you have to keep it dynamic 
and vibrant because kids get tired of seeing the same slides every year…Operation UNITE has 
been a dynamic program.” 
II. Community Environmental Factors in Eastern Kentucky  
Interviewees discussed several community environmental factors unique to Eastern Kentucky 
that they believed had contributed to the observed declines in drug overdose mortality.  
A. Longstanding Political Commitment to Addressing Substance Use in the 
Region  
Respondents described the consistent and bipartisan political support from influential leaders like 
Congressman Hal Rogers (R; 1981‒present) and Governors Ernie Fletcher (R; 2003‒2007) and 
Steve Beshear (D; 2007‒2015), who ensured the allocation of resources and attention to opioid 
misuse concerns in Kentucky. Respondents believed that Congressman Rogers’ longstanding 
commitment to addressing opioid misuse in his district contributed to the observed overdose 
mortality declines in the region. Congressman Rogers launched Operation UNITE in 2003, in 
response to a special report published in the Lexington Herald-Leader newspaper titled, 
“Prescription for Pain.”22  
Respondents consistently highlighted this early political support as a key factor in creating an 
environment that supported treatment and recovery. A treatment expert shared that Senator 
Markey (D; Massachusetts) called Rogers “the Paul Revere of the national opioid crisis.” Rogers 
helped ensure priority funding to organizations like Operation UNITE, which provided resources 
within the region long before the implementation of Medicaid expansion, and brought attention 
to the gravity of drug addiction before others.   
Before Kentucky Medicaid coverage was expanded in 2014, Eastern Kentucky did not have 
treatment facility beds readily available. A representative from the criminal justice sector 
explained, “There would be times when we would have someone in Eastern Kentucky needing a 
bed and we couldn’t find one unless it was 500 miles away.” During this time, Operation UNITE 
helped individuals find treatment facilities with vacant beds by implementing a state hotline and 
website, findhelpnowky.org, in partnership with the University of Kentucky’s Injury Prevention 
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Research Center, which is still in use today. Prior to Medicaid expansion, Operation UNITE’s 
treatment vouchers were one of the main sources of funding for treatment and recovery services, 
making UNITE an essential stakeholder supporting Kentucky’s longstanding history of 
addressing addiction concerns.   
A stakeholder from the recovery sector explained how Governor Fletcher facilitated continued 
growth of the recovery housing community. Fletcher learned of the peer-led, service model of 
recovery housing that was taking place in Louisville and Lexington and recognized the need to 
replicate this model in Eastern Kentucky. With regard to expanding the recovery housing model, 
the recovery expert explained that Fletcher “brought all the agencies into one room [and said] we 
need to figure this out so we can fund these.” 
Additionally, several respondents noted that former Kentucky Governor Steve Beshear had a 
significant impact on addressing SUD and helped Kentucky residents access affordable 
treatment. A stakeholder from the treatment sector explained, “In the summer of 2014, former 
Governor Beshear…became a national leader in rolling out the Affordable Care Act, the 
Medicaid expansion, and when they did the Medicaid expansion they had the forethought to put 
a SUD treatment benefit for all levels of care” for all Medicaid enrollees.  Substance use 
treatment providers interviewed as part of this study noted that since Kentucky’s implementation 
of Medicaid expansion in 2014, Medicaid has been the primary source of funding for addiction 
treatment services within their facilities. With a robust existing treatment and recovery network, 
this commitment to expanding affordability allowed Kentucky to effectively address SUD in the 
state’s Eastern region.  
B. Appalachian Culture 
Respondents discussed how the notion of an Appalachian culture or shared identity helped 
Eastern Kentucky residents come together to recognize and find innovative solutions to addiction 
issues. A respondent from the health care field noted, “The people in Appalachia are resilient 
people but have had a lot of adversity.” This adversity was evidenced by job loss, lack of 
economic growth in the region, higher rates of addiction and deaths of despair, and high rates of 
drug overdose mortality. While these challenges contributed to a stigma that is often associated 
with the Appalachian region, they also created opportunities for residents of Appalachia to come 
together and redefine what it meant to live in an Appalachian community in which residents look 
out for one another, build capacity, engage other members of the community, and work to 
address addiction and drug overdose mortality. A representative from Operation UNITE 
illustrated the resilience of Appalachian communities when they said, “Appalachian 
communities are independent. They take care of themselves. This was an issue that has truly 
brought all of us together because what happened in Pike [County] impacts Harlan [County] and 
so forth.”  
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A representative from the criminal justice community discussed some of the grassroots efforts 
taking place to address SUD: “People starting these [programs] are from here; they know 
everyone and take more vested interest.” This idea of local coalitions taking care of community 
members speaks to the strength and influence the Appalachian identity and culture had on 
organizations working to mitigate SUD issues; not only did these local coalitions want to help 
those struggling with SUD, but they had a shared identity that they attributed to being from the 
Appalachian region.  
C. Partnerships, Coalitions, and Collaboration  
Several respondents discussed the contributions of partnerships, coalitions, and community 
collaboration to the observed declines in overdose mortality. They noted that robust and cross-
sector collaborations among local partners have made it possible to take a multifaceted approach 
to address issues related to addiction and drug use in the region. Key partners included treatment 
and recovery organizations, state and local health departments, the criminal justice system, faith-
based organizations, and local nonprofits. A criminal justice representative explained, 
“Everybody at the table now has learned this is not a one agency problem—we have to all say 
this is my part and your part now let’s make it work.” According to community stakeholders, this 
collective engagement has been central to making the region’s treatment and recovery 
community so robust and successful.  
Additionally, while these collective efforts provided the region with a diverse array of resources, 
they also provided a support system for those experiencing SUD to help them through their 
recovery. A stakeholder from the recovery sector explained, “Through community action and 
community involvement collaboration, it provides this network or web of assistance” and these 
collaborations provide “an extra layer of insulation against the isolation that occurs in addiction.”   
D. Reduced Stigma  
Stigma around SUD was a common theme throughout interviews across stakeholder groups. 
Respondents identified reduced stigma as a facilitator for increasing treatment enrollment and 
support to address SUD issues. Respondents discussed a general reduction in stigma, but 
frequently highlighted changes in stigma stemming from increased community support for 
treatment and recovery and changing attitudes within the criminal justice system.  
Community Support. When discussing the observed declines in mortality, a respondent from the 
economic development sector noted, “[Substance use] is getting talked about a lot more, not kept 
underground anymore. Some people aren’t as ashamed as they used to be to get into recovery 
and get help.” In the late 2000s and early 2010s, overdose mortality and issues concerning 
substance use were sources of embarrassment; however, as substance use became more 
widespread, community members started to recognize these issues as ubiquitous instead of 
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isolated. A health care representative illustrated this point: “Everyone knows someone in their 
family that has some kind of substance abuse—I think people realize it can happen to them, it is 
on their back door.” 
 
Criminal Justice. Respondents shared that reduced stigma within the criminal justice system has 
led to increased treatment enrollment and decreased incarceration rates. When asked about the 
facilitators to treatment enrollment, a criminal justice representative explained, “The issue got so 
bad it was difficult to find someone who hasn’t had an experience in their personal life.” They 
noted that the increase in broader community support also contributed to a reduction in stigma 
throughout the criminal justice system. 
 
Another criminal justice sector respondent discussed how the criminal justice system initially 
tried to use incarceration as a way to solve the addiction problem, and realized this course of 
action was not effective. They explained how the courts started to use treatment and rehab 
programs as an alternative to incarceration and outlined the positive impact of this altered 
approach:23 “People know what they are talking about because they see the results, they see the 
people who remain sober, got their kids back.”  
III. Shifts in Drug Use Patterns  
While respondents discussed many of the positive reasons they believed Eastern Kentucky saw a 
decline in drug overdose mortality rates, they also frequently mentioned shifting drug use 
patterns in the region. Across all sector types, interview respondents described the increased use 
of methamphetamines, in particular, as a primary contributing factor to reduced opioid mortality 
rates as access to prescription opioids declined. Treatment providers reported that a higher 
percentage of their clients indicated that methamphetamine was their primary drug of choice. For 
example, ARC stated that 6 percent of their clients reported methamphetamine as their drug of 
choice in 2014, compared to 27 percent in 2017, and over 40 percent currently (as of April 
2020). Similarly, a representative from the recovery sector stated, “Our drug of choice in 
recovery centers is meth. Not that we don’t see opiates, but the trends have gone down 
significantly. The drug of choice statewide is meth. It used to be only in western Kentucky, but 
now it is in Eastern Kentucky.” Additionally, some respondents in the region reported that there 
was not a dramatic shift in Eastern Kentucky to heroin use when the supply of prescription 
opioids declined, because heroin was not readily available, as it was in other parts of the state. 
This may have also been a contributing factor to the declining rates of drug overdose mortality.  
There were differences in opinion about when the rise in use of methamphetamine began, which 
may have been influenced by different trends across the region. Some respondents reported that 
the rise in methamphetamine was more recent, within the past few years, while others believed 
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the increase in Eastern Kentucky began when the access to prescription opioids was limited. The 
source of methamphetamine has also changed over the past 10 years. One representative from 
law enforcement described that the methamphetamine “used to be home cooked, but is available 
now from Mexican drug trafficking organizations. [They are] seeing more and more meth than 
we saw 10 to 12 years ago” in terms of seizures. While the methamphetamine supply chain 
shifted, the cost also declined: “The cost of methamphetamine has gone down, which tells me the 
supply is meeting the demand.” The imported methamphetamine is easier for people who use it 
to obtain, since they do not have to cook it themselves, cheaper, and more potent than home-
cooked methamphetamine.24  
The reason that the shift in drug use from opioids to methamphetamine contributed to the decline 
in drug overdose mortality was that methamphetamine use alone does not often lead to acute 
fatal overdose; however, many other negative health and social consequences are associated with 
methamphetamine use. As one respondent said, “The difference in meth is it is not a drug that 
will take a person’s life, it just makes them crazy.” Another respondent said, “With meth, you 
don’t see the acute overdoses as often as you do with opiates. It’s just as devastating, but it 
doesn’t have [a] sedative effect.” Respondents also described the longer-term impacts of 
sustained methamphetamine use, including “30-year-olds blowing heart valves.” A 
representative from the treatment sector stated, “Meth kills you slower. You are still going to die 
from it eventually, but it doesn’t cause the levels of respiratory arrest.” 
Law enforcement professionals described that with methamphetamine, “You get more violent 
people, more drug-induced psychosis. There is a lot of paranoia, and they are more likely to 
fight. They carry guns. Didn’t see that as much with opioids.” While it may not lead to a fatality 
that is reported as a drug overdose, respondents noted that methamphetamine contributes to 
mortality rates in many indirect ways, in addition to other many health and social 
consequences.25 Additionally, some representatives from the treatment sector said that people do 
not seek treatment for methamphetamine as often as for opioids. Additionally, there are not MAT 
options for methamphetamine use, like there are for opioid use, which makes treatment more 
difficult and the long-term success rate lower.  
IV. Impact of COVID-19 Pandemic  
Data collection for this project occurred during the early phases of the COVID-19 pandemic, and 
some respondents reflected on the impacts of the COVID-19 pandemic on substance use 
treatment and drug overdose prevention. For example, a few respondents noted that individuals 
released from jail as a result of the pandemic may have been at higher risk of overdose if they 
were not provided appropriate support services and resources. Some respondents conveyed 
anecdotal observations regarding spikes in overdoses occurring after measures to mitigate the 
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spread of coronavirus were implemented. Respondents noted that COVID-19 has impacted the 
services provided by treatment centers, in-person recovery and support communities, and the 
overall economic environment of these communities. One respondent noted that a positive 
consequence of the COVID-19 response has been the increased focus on telehealth among the 
treatment community. However, the dramatic rise in unemployment and social isolation resulting 
from shutdowns remain a significant concern for individuals with and people working to address 
SUD.  
Limitations 
We recognize several limitations associated with this study. First, study findings were based on 
the thoughts and opinions of local and state stakeholders within Kentucky. While researchers 
have worked to identify consistent themes across respondents, data may not be generalizable to 
other settings. Second, the complex nature and multiple factors influencing shifts and declines in 
drug overdose mortality made it difficult to assess the relative importance of various factors 
contributing to observed declines. Because this was a qualitative study, it was impossible to 
ascertain which components of the holistic approach to prevention had the greatest impact on the 
declines in drug overdose mortality. Third, due to COVID-19 social distancing guidelines, we 
could not travel to the region to collect data in-person as we originally planned, which may have 
changed conversation dynamics and influenced final data collection.  
Implications 
Eastern Kentucky achieved notable success in reducing drug overdose mortality, and this study 
highlighted some of the strategies that key informants believed were successful in reducing 
overdose mortality, which may be adapted and leveraged by other states and communities. 
Respondents discussed how the region’s longstanding focus and commitment from partners, 
stakeholders, and policymakers to address SUD has led to positive outcomes, including declines 
in mortality, increased access to treatment, and reduced stigma. Kentucky has enacted many 
policies to improve prescribing behaviors. Additionally, Medicaid expansion and additional 
substance use treatment benefits led to a dramatic increase in the availability of treatment options 
in Eastern Kentucky, which respondents noted likely contributed to declines in drug overdose 
mortality. Eastern Kentucky also focused on creating an environment that promoted long-term 
recovery for people with SUD, for example, increasing access to recovery housing and 
advocating for second chance employment opportunities. Respondents discussed the impact of 
reduced stigma, specifically among the police, judicial system, employers, and the broader 
community. Respondents noted other factors that may have contributed to declines in drug 
overdose mortality, including increased access to naloxone and education and prevention efforts.  
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In addition to these positive factors, respondents discussed the shift in drug use patterns—
specifically to an increased use of methamphetamine—as one of the major contributing factors to 
the declines in drug overdose mortality. Because methamphetamine is less likely than opioids to 
cause acute fatal overdose, a shift to more use of methamphetamine could lead to a decline in 
drug overdose mortality, but may not indicate a decline in substance use within the region. There 
were significant concerns associated with the increase in methamphetamine use, including 
longer-term health impacts, increased violence perpetration among individuals using 
methamphetamine and increased crime within the community, and lower success rates for 
treatment. One respondent pointed out that until underlying substance use issues are addressed, 
substances will be substituted and shift as the supply of substances changes. Considerations for 
how resources and funding may address all SUD, not solely opioid use disorder, may be 
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